DE3585578D1 - Hepatitisoberflaechenantigenpartikelvakzin. - Google Patents

Hepatitisoberflaechenantigenpartikelvakzin.

Info

Publication number
DE3585578D1
DE3585578D1 DE8585107328T DE3585578T DE3585578D1 DE 3585578 D1 DE3585578 D1 DE 3585578D1 DE 8585107328 T DE8585107328 T DE 8585107328T DE 3585578 T DE3585578 T DE 3585578T DE 3585578 D1 DE3585578 D1 DE 3585578D1
Authority
DE
Germany
Prior art keywords
hepatitis
vaccines
surface anti
particle vaccine
hepatitis surface
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Revoked
Application number
DE8585107328T
Other languages
English (en)
Inventor
Pablo D T Valenzuela
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Vaccines and Diagnostics Inc
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24491503&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE3585578(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiron Corp filed Critical Chiron Corp
Application granted granted Critical
Publication of DE3585578D1 publication Critical patent/DE3585578D1/de
Anticipated expiration legal-status Critical
Revoked legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
DE8585107328T 1984-06-18 1985-06-13 Hepatitisoberflaechenantigenpartikelvakzin. Revoked DE3585578D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62175684A 1984-06-18 1984-06-18

Publications (1)

Publication Number Publication Date
DE3585578D1 true DE3585578D1 (de) 1992-04-16

Family

ID=24491503

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585107328T Revoked DE3585578D1 (de) 1984-06-18 1985-06-13 Hepatitisoberflaechenantigenpartikelvakzin.

Country Status (5)

Country Link
EP (1) EP0174444B1 (de)
AT (1) ATE73349T1 (de)
CA (1) CA1341021C (de)
DE (1) DE3585578D1 (de)
HK (1) HK140095A (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5324513A (en) * 1984-03-07 1994-06-28 Institut Pasteur Composition useful for the fabrication of vaccines
EP0171908A3 (de) * 1984-07-11 1987-07-15 Takeda Chemical Industries, Ltd. Hepatitis-B-Virus-Oberflächenantigen und dessen Herstellung
JPS6137738A (ja) * 1984-07-31 1986-02-22 Tetsuo Nakamura Ｂ型肝炎ワクチン
IE59389B1 (en) * 1986-05-23 1994-12-23 Merck & Co Inc Method for producing hepatitis b virus core antigen (HBcAg) in yeast
DE3788902T3 (de) * 1986-06-17 2004-11-25 Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville Hepatitis-Delta-Diagnostika und Impfstoffe, ihre Herstellung und Verwendung.
JPH089637B2 (ja) * 1986-06-18 1996-01-31 財団法人阪大微生物病研究会 Ｂ型肝炎ウイルス抗原とその製造法
EP0278940A3 (de) * 1987-01-30 1988-12-07 Smithkline Biologicals S.A. Hepatitis-B-Virus-Oberflächenantigene und sie enthaltende hybride Antigene
EP0310178A1 (de) * 1987-09-30 1989-04-05 Merck & Co. Inc. Reinigung des preS2+S-Antigens
US5547834A (en) * 1988-01-29 1996-08-20 Chiron Corporation Recombinant CMV neutralizing proteins
WO1989007143A1 (en) 1988-01-29 1989-08-10 Chiron Corporation Recombinant cmv neutralizing proteins
AT392417B (de) * 1989-09-20 1991-03-25 Immuno Ag Komplex geeignet zur durchfuehrung eines verfahrens zur reinigung von pre-s-hepatitis-b- virus-oberflaechenantigen
LT3988B (en) 1992-02-17 1996-06-25 Fermentas Biotech Inst Recombinant plasmides pfs19, pfps2-48 and pjlfds1 codingsynthesis of human hepatite b of surfice virus antigenes, methods fof producing thereof
ES2310062B1 (es) 2005-07-15 2009-11-13 Bionostra, S.L. Particulas pseudovirales vacias quimericas derivadas del virus causante de la enfermedad de la bursitis infecciosa (ibdv), procedimiento de obtencion y aplicaciones.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR76274B (de) * 1981-08-04 1984-08-04 Univ California
JPS58146281A (ja) * 1981-10-19 1983-08-31 Suntory Ltd 酵母細胞の形質転換法
EP0105141A3 (de) * 1982-09-09 1985-12-04 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Rekombinante DNS Moleküle, Verfahren zu deren Herstellung, deren Verwendung zur Herstellung von Hepatitis B Oberflächen-Antigen (HBsAg) und pharmazeutische Zusammensetzungen die das HBsAg enthalten
JPS5974985A (ja) * 1982-10-19 1984-04-27 Takeda Chem Ind Ltd 新規ｄｎａ
JPS5980615A (ja) * 1982-10-29 1984-05-10 Takeda Chem Ind Ltd Ｄｎａおよびその用途
EP0171908A3 (de) * 1984-07-11 1987-07-15 Takeda Chemical Industries, Ltd. Hepatitis-B-Virus-Oberflächenantigen und dessen Herstellung

Also Published As

Publication number Publication date
HK140095A (en) 1995-09-08
ATE73349T1 (de) 1992-03-15
EP0174444A3 (en) 1987-07-29
CA1341021C (en) 2000-06-13
EP0174444A2 (de) 1986-03-19
EP0174444B1 (de) 1992-03-11

Similar Documents

Publication Publication Date Title
EP0278940A3 (de) Hepatitis-B-Virus-Oberflächenantigene und sie enthaltende hybride Antigene
FI893702A (fi) Foerfarande foer mikrobiologisk framstaellning av humant serumalbumin och andra heterologa proteiner ur jaest.
AU6733487A (en) Mammalian interleukin-4
ATE105334T1 (de) Schimaerische glykoproteine enthaltende immunogenische abschnitte von menschlichem parainfluenzavirus typ 3.
KR900700508A (ko) 인간의 호흡기 합포체성 바이러스에 대한 당단백질 면역 단편을 함유하는 키메라(chimeric) 당단백질
CA2143823A1 (en) Retro-, inverso - and retro-inverso synthetic peptide analogues
DE3585578D1 (de) Hepatitisoberflaechenantigenpartikelvakzin.
DE3584866D1 (de) Hybridpartikel-immunogene.
AU1013601A (en) Method of inducing and/or enhancing an immune response to tumor antigens
AU2403188A (en) Infectious bovine rhinotracheitis virus mutants, vaccines containing same, methods for the production of same and methods for the use of same
EP0293827A3 (de) Probe für Leishmaniosis
DE68926274D1 (de) Rekombinante HBsAg Hybridpartikel, die morphologische Eigenschaften von HBsAg-Antigen haben und eine immunogene Sequenz enthalten, die neutralisierende Antikörper gegen HIV induziert oder die von diesen Antikörpern erkannt ist, Nukleotide Sequenzen, die diese Partikel codieren und sie enthaltende Impfstoffe
AU7547987A (en) Method of preparation and use for feline leukemia virus antigens
EP0496787A4 (en) Novel infectious bursal disease virus
ES2012815A6 (es) Un metodo para producir peptidos antigenicos relacionados con el antigeno p97 asociado a melanoma, y para preparar vacunas que los contienen.
FR2580176B1 (fr) Vaccin antirabique avirulent
AU606574B2 (en) Hepatitis b surface antigen formed by recombinant dna techniques, vaccines diagnostics, cell lines and methods of forming same
TH1016EX (th) การประดิษฐ์และการใช้กรดดีออกซีไรโบนิวคลีอิค(กรรมวิธี)
TH1016A (th) การประดิษฐ์และการใช้กรดดีออกซีไรโบนิวคลีอิค(กรรมวิธี)

Legal Events

Date Code Title Description
8363 Opposition against the patent
8331 Complete revocation